SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " fda " 2,441 found 🔀 AI-powered Shuffle
Bears Sign Ex-Packers Safety After Cutting Loose Preseason Star
The Chicago Bears have signed a former Green Bay Packers draft pick and safety after cutting ties with one of their preseason standouts. The post Bears Sign Ex-Packers Safety After Cutting Loose Preseason Star appeared first on HEAVY.
Seahawks lose player to Klint Kubiak’s Raiders in waiver claim
The Seahawks lose an offensive lineman to Klint Kubiak’s Raiders.
These Angels Are Flunking Their Audition For Next Season
The Los Angeles Angels have been conducting tryouts for next year, and most of the results haven't been pretty.
Ashton Jeanty will play in Week 1
Ashton Jeanty will face the Dolphins' defense in Week 1.
Bloomsburg Children’s Museum now accepting registrations for annual science fair
Students in grades 6-12 can now register for the Bloomsburg Children’s Museum’s 12th Annual Science Fair, which will be held in January.
Arsenal close to finalising new contract for Arteta
Mikel Arteta is believed to be close to finalising a new contract with Premier League champions Arsenal.
ESPN Weighs in on Alabama's Chances Against Kentucky
ESPN has weighed in with a matchup predictor prediction for the Alabama Crimson Tide against Kentucky.
Romeo Doubs vows to be better after disappointing Patriots debut
The wide receiver finished with zero catches against the Seahawks.
Eyewitness Sports Scoreboard for Thursday, September 10
As the first week of school comes to an end, the high school sports season goes into full swing!
Bold predictions for Thursday Night Football in NFL Week 1
Bold predictions for the Rams vs 49ers in Australia.
Why Ohio State football remains committed to marquee nonconference matchups
Ohio State hasn't added a home-and-home series in years, but remains committed to playing high-profile nonconference games like its latest with Texas.
'This is the Liverpool we want to see'
Atletico Madrid were impressive and we managed to overcome them with a mixture of skill and intensity, and as for entertainment, both teams provided an endless amount over the 90 minutes. Kate: This is the Liverpool we want to see. Mac Allister's goal was sublime.
O’Gorman motivated for 48th Dakota Bowl
SIOUX FALLS (KELO) – The Dakota Bowl is one of the biggest football games of the year for O’Gorman High School, which is something future Knights are taught from a young age. “I think our players, starting with all six of the guys that we had here today, that started our council, were kindergartners that […]
Capcom Announces Mega Man: Dual Override amiibo, Here's A First Look
Arriving the "same day" as the new game
Foley man charged in multiple burglaries after being caught inside business
A 33-year-old Foley man is facing multiple charges after police reportedly caught him inside a business Wednesday and linked him to several other recent break-ins.
Who is Sam Darnold's backup after Week 1 injury?
The good news: Drew Lock has starting experience. The bad news: what Drew Lock has done with said experience.
Ja'Marr Chase a full go Wednesday
Bengals WR Ja'Marr Chase was a full participant in practice while dealing with a knee injury
Mika Baur delighted to open his scoring account for Celtic
Mika Baur produced a Man of the Match performance at McDiarmid Park, scoring the only goal of the game to give Celtic a 1-0 victory over St Johnstone and all three points.The win made it six out of si...
Why didn't the Seahawks keep Kenneth Walker III?
The Seahawks spent big to keep their core together -- but that didn't include the reigning Super Bowl MVP.
Private Equity’s Next Focus: Profitable Niche Businesses
After years of targeting industries like veterinary practices and plumbing companies, experts say private equity is focusing on more profitable niche businesses.
Business tidbits: Charlotte Russe to open in Valley Mall, new restaurant in Selah
A San Francisco-based retail chain specializing in clothing for women in their teens and 20s is opening next week at Valley Mall in Union Gap.
New York Giants Basically Just Admitted an Expensive Failure
Looks like this might have been a waste of money for the New York Giants.
ARPA-H to invest $62 million to develop FDA-authorized AI to help treat heart failure
ARPA-H, the government agency that funds cutting edge health research, plans to commit $62.7 million to develop artificial intelligence bots that direct
Former Angels, Braves 5.60 ERA reliever released by Athletics
The left-hander has pitched for three MLB teams in 2026.
How titanosaurs hatched eggs in cooler climates
Fossil eggshells believed to be from some of the biggest dinosaurs that ever lived have been found in a surprisingly cool climate far from the equator. But those titanosaurs were too big to sit on their eggs. Microscopic evidence shows what they did instead to keep the eggs warm enough to hatch.
The Cost of Cutting American Science: How Federal Cuts Diminish Public Health Capacity
Among the federal government’s many responsibilities is the work it does to protect public health. Federal agencies monitor our food supply to ensure safety, conduct research to better understand emerging health threats, provide funding for public health programs in communities and work to detect and respond to disease outbreaks. Americans rely on these efforts every day—in a 2024 online survey, 74% of respondents said that “if the federal government issued safety guidance about food you eat regularly,” they would follow it. Changes to Federal Public Health Capacity The Trump administration’s efforts to reshape the federal government have resulted in significant impacts on our nation’s public health capacity over the past 20 months, affecting the response to health concerns such as measles, Ebola and cyclosporiasis. Agencies with core public health, food safety and disease prevention responsibilities experienced large workforce decreases during the first year of the administration. At the Centers for Disease Control and Prevention, for instance, the workforce in February 2026 was 26.7% smaller than in September 2024 before the start of the Trump administration. The Food and Drug Administration saw a similarly steep decline of 21.6%. Agencies such as the National Institutes of Health, Substance Abuse and Mental Health Services Administration and Food Safety and Inspection Service also experienced large workforce decreases. (function(){function e(){window.addEventListener(`message`,function(e){if(e.data[`datawrapper-height`]!==void 0){var t=document.querySelectorAll(`iframe`);for(var n in e.data[`datawrapper-height`])for(var r=0,i;i=t[r];r++)if(i.contentWindow===e.source){var a=e.data[`datawrapper-height`][n]+`px`;i.style.height=a}}})}e()})(); Changes can also be seen in crucial public health occupations. The number of federal food inspectors, for example, decreased by more than half between September 2024 and February 2026, going from 1,035 to 473. This is the lowest number of food inspectors employed by the federal government since at least 2005. By February 2026, there were also 33.3% fewer federal public health program specialists, whose work includes advising federal funding recipients on public health activities and analyzing the effectiveness of public health programs. Government’s capacity is diminished as employees with specialized knowledge and experience in protecting the public and responding to health risks depart, leaving agencies less prepared to carry out their public health missions. There also have been vacancies in critical high-level leadership positions at public health agencies, most notably at the CDC, which had a permanent Senate-confirmed director for less than a month between January 2025 and early August 2026. Although the CDC has previously been led by acting directors at the start of an administration, the nearly yearlong gap since the departure of the administration’s first permanent director in August 2025 is without precedent. As of August 2026, the FDA is also currently without a Senate-confirmed commissioner following the previous commissioner’s resignation in May 2026. Additionally, public health agencies are experiencing increased politicization of their leadership ranks. In agencies such as the CDC and Food Safety and Inspection Service, the number of individuals in the Senior Executive Service—the most senior career leaders in government—has declined significantly, while at the same time the number of political appointees has reached record levels. (function(){function e(){window.addEventListener(`message`,function(e){if(e.data[`datawrapper-height`]!==void 0){var t=document.querySelectorAll(`iframe`);for(var n in e.data[`datawrapper-height`])for(var r=0,i;i=t[r];r++)if(i.contentWindow===e.source){var a=e.data[`datawrapper-height`][n]+`px`;i.style.height=a}}})}e()})(); (function(){function e(){window.addEventListener(`message`,function(e){if(e.data[`datawrapper-height`]!==void 0){var t=document.querySelectorAll(`iframe`);for(var n in e.data[`datawrapper-height`])for(var r=0,i;i=t[r];r++)if(i.contentWindow===e.source){var a=e.data[`datawrapper-height`][n]+`px`;i.style.height=a}}})}e()})(); At the CDC, for example, the number of career SES decreased 42.9% between December 2024 and February 2026, while the number of non-Senate confirmed political appointees at the agency was six times larger than the agency’s historical average from 2009 and 2024. Knowledgeable career leaders are integral to the ability of public health agencies to carry out their work with scientific integrity and professional judgment, and rapid leadership turnover and increased politicization threaten agencies’ ability to make evidence-based decisions to protect our health. The upheaval and politicization in public health agencies have also negatively affected employee engagement. Strong employee engagement is crucial to the ability of agencies to carry out their mission and successfully provide essential services to the public. In the 2025 Public Service Viewpoint Survey conducted by the Partnership for Public Service, the Department of Health and Human Services—which encompasses major public health agencies such as the CDC and FDA—had an employee engagement and satisfaction score of 20.4 out of 100, one of the lowest among large agencies. Only 2.8% of HHS employees indicated trust in their political leaders and only 8.7% reported confidence that they could report a suspected violation of law or regulation without retaliation. Employees at HHS also reported that the agency’s ability to provide services to the public had suffered. Nearly half of employees at HHS, 47.5%, said their work unit was worse at delivering quality services compared to its performance in 2024. In addition, 57.8% said their work unit was performing worse at fulfilling stakeholder needs. In addition to the work done within federal agencies, the federal government also distributes significant funding for public health and disease prevention work to state and local governments, nonprofits and small businesses—funding which has been significantly disrupted. At the CDC, for example, there was a 71.9% decrease in the amount of project grant funding issued in fiscal year 2025 compared to fiscal year 2024. The FDA also issued far less funding in fiscal year 2025—a 21.3% decrease from its fiscal year 2024 funding. Changes in federal funding include the ending of grants to community organizations that worked on HIV prevention and the cancellation of funding for research into improvements to patient safety and healthcare quality. These changes go beyond federal agencies to impact the broader public health ecosystem, including the state and local health departments responsible for much of the on-the-ground public health work in their communities. About 80% of the CDC’s domestic funding is directed towards state and local partners—meaning that cuts to CDC funding can ultimately result in cuts to state and local public health capacity. Federal agencies also provide expertise and assistance to state and local health agencies as they deal with particular health challenges, but workforce cuts have resulted in fewer federal employees available to help. The Impact of Changes to Public Health Capacity These changes to federal public health capacity are not abstract concerns. Disrupted programs, reduced funding and lost expertise at public health agencies across all levels of government threaten the public’s physical well-being and safety. In some cases, this has already led to harm. The most immediate impacts of federal cuts were seen in interruptions to ongoing public health programs and crisis responses. In one instance, when CDC grants were canceled during the 2025 Texas measles outbreak—the most severe measles outbreak in 25 years—public health officials in Lubbock, Texas were forced to pause parts of their measles response work supported by the frozen funding. Lubbock’s director of public health further said that a lack of available CDC experts to reach out to for advice “definitely” impacted the department’s response to the measles crisis. Cuts to federal funding also forced Dallas County Health and Human Services to cut staff and cancel 50 community vaccination clinics during the outbreak. Public health work outside of major outbreak responses was also disrupted. For example, in April 2025, the Milwaukee Public Health Department was unexpectedly unable to reach experts on lead poisoning due to firings at the CDC when responding to concerns about lead contamination in Milwaukee public schools. Due to federal workforce cuts, several programs at the CDC, including Alzheimer’s and epilepsy programs, have also become trapped in limbo—existing on paper, but without the staff necessary to operate. More recent crises reveal how federal cuts have weakened the public health infrastructure needed to prevent and respond to dangerous new outbreaks. Internationally, cuts at the U.S. Agency for International Development eliminated funding for disease testing and contact tracing abroad, which delayed detection of and responses to the 2026 Ebola outbreak in the Democratic Republic of Congo. While international outbreaks may seem far removed, the unchecked spread of disease in any country can quickly pose a danger to economic well-being, security and health around the world. Within the United States, public health cuts inhibited responses to the summer 2026 outbreak of the food-borne parasite cyclospora. At the federal level, cuts to funding for lab equipment and for CDC staff with expertise in parasitic infections—including 9 out of 11 staff members at the lab responsible for identifying parasitic outbreaks in 2025— contributed to the largest reporting delay in outbreak cases at the CDC in 15 years. Conflicting communications from the FDA about the source of the outbreak, which followed cuts to the agency’s communications department, additionally led to confusion among the public about how to best avoid infection. At the same time, cuts to HHS funding and support for local and state public health slowed some health departments’ responses to the crisis. The exact costs of these delays, constraints and confusion in public health responses are difficult to estimate. However, their message is clear: federal cuts have already made containing threats to public health even more of a challenge. Conclusion Protecting public health—from food safety to disease prevention—is one of the federal government’s most important missions. Dramatic and haphazard cuts to federal agencies and funding have already disrupted the public health system, impacting the response to challenges such as measles, lead poisoning and cyclosporiasis. The U.S. public health system needed improvement before these disruptions. Since 2022, federal leadership and coordination in response to public health outbreaks has been on the Government Accountability Office’s High-Risk List of areas in need of attention to improve government effectiveness and efficiency. Recent cuts only compound these concerns. The chaotic dismantling of government and resulting disruptions to crucial functions like public health and disease prevention highlight the need for meaningful reform and concrete policy proposals to reimagine how government can better serve the public and be more effective, responsive and accountable. To learn more about the impact of federal cuts to public health and science more broadly, visit The Cost of Cutting American Science. Learn more For more information on the Partnership for Public Service’s government reform initiative, visit Government for a New Era. View here In line with The Cost of Cutting American Science, federal workforce data in this brief is as of February 2026
The Cost of Cutting American Science: How Federal Cuts Diminish Public Health Capacity
Among the federal government’s many responsibilities is the work it does to protect public health. Federal agencies monitor our food supply to ensure safety, conduct research to better understand emerging health threats, provide funding for public health programs in communities and work to detect and respond to disease outbreaks. Americans rely on these efforts every day—in a 2024 online survey, 74% of respondents said that “if the federal government issued safety guidance about food you eat regularly,” they would follow it. Changes to Federal Public Health Capacity The Trump administration’s efforts to reshape the federal government have resulted in significant impacts on our nation’s public health capacity over the past 20 months, affecting the response to health concerns such as measles, Ebola and cyclosporiasis. Agencies with core public health, food safety and disease prevention responsibilities experienced large workforce decreases during the first year of the administration. At the Centers for Disease Control and Prevention, for instance, the workforce in February 2026 was 26.7% smaller than in September 2024 before the start of the Trump administration. The Food and Drug Administration saw a similarly steep decline of 21.6%. Agencies such as the National Institutes of Health, Substance Abuse and Mental Health Services Administration and Food Safety and Inspection Service also experienced large workforce decreases. (function(){function e(){window.addEventListener(`message`,function(e){if(e.data[`datawrapper-height`]!==void 0){var t=document.querySelectorAll(`iframe`);for(var n in e.data[`datawrapper-height`])for(var r=0,i;i=t[r];r++)if(i.contentWindow===e.source){var a=e.data[`datawrapper-height`][n]+`px`;i.style.height=a}}})}e()})(); Changes can also be seen in crucial public health occupations. The number of federal food inspectors, for example, decreased by more than half between September 2024 and February 2026, going from 1,035 to 473. This is the lowest number of food inspectors employed by the federal government since at least 2005. By February 2026, there were also 33.3% fewer federal public health program specialists, whose work includes advising federal funding recipients on public health activities and analyzing the effectiveness of public health programs. Government’s capacity is diminished as employees with specialized knowledge and experience in protecting the public and responding to health risks depart, leaving agencies less prepared to carry out their public health missions. There also have been vacancies in critical high-level leadership positions at public health agencies, most notably at the CDC, which had a permanent Senate-confirmed director for less than a month between January 2025 and early August 2026. Although the CDC has previously been led by acting directors at the start of an administration, the nearly yearlong gap since the departure of the administration’s first permanent director in August 2025 is without precedent. As of August 2026, the FDA is also currently without a Senate-confirmed commissioner following the previous commissioner’s resignation in May 2026. Additionally, public health agencies are experiencing increased politicization of their leadership ranks. In agencies such as the CDC and Food Safety and Inspection Service, the number of individuals in the Senior Executive Service—the most senior career leaders in government—has declined significantly, while at the same time the number of political appointees has reached record levels. (function(){function e(){window.addEventListener(`message`,function(e){if(e.data[`datawrapper-height`]!==void 0){var t=document.querySelectorAll(`iframe`);for(var n in e.data[`datawrapper-height`])for(var r=0,i;i=t[r];r++)if(i.contentWindow===e.source){var a=e.data[`datawrapper-height`][n]+`px`;i.style.height=a}}})}e()})(); (function(){function e(){window.addEventListener(`message`,function(e){if(e.data[`datawrapper-height`]!==void 0){var t=document.querySelectorAll(`iframe`);for(var n in e.data[`datawrapper-height`])for(var r=0,i;i=t[r];r++)if(i.contentWindow===e.source){var a=e.data[`datawrapper-height`][n]+`px`;i.style.height=a}}})}e()})(); At the CDC, for example, the number of career SES decreased 42.9% between December 2024 and February 2026, while the number of non-Senate confirmed political appointees at the agency was six times larger than the agency’s historical average from 2009 and 2024. Knowledgeable career leaders are integral to the ability of public health agencies to carry out their work with scientific integrity and professional judgment, and rapid leadership turnover and increased politicization threaten agencies’ ability to make evidence-based decisions to protect our health. The upheaval and politicization in public health agencies have also negatively affected employee engagement. Strong employee engagement is crucial to the ability of agencies to carry out their mission and successfully provide essential services to the public. In the 2025 Public Service Viewpoint Survey conducted by the Partnership for Public Service, the Department of Health and Human Services—which encompasses major public health agencies such as the CDC and FDA—had an employee engagement and satisfaction score of 20.4 out of 100, one of the lowest among large agencies. Only 2.8% of HHS employees indicated trust in their political leaders and only 8.7% reported confidence that they could report a suspected violation of law or regulation without retaliation. Employees at HHS also reported that the agency’s ability to provide services to the public had suffered. Nearly half of employees at HHS, 47.5%, said their work unit was worse at delivering quality services compared to its performance in 2024. In addition, 57.8% said their work unit was performing worse at fulfilling stakeholder needs. In addition to the work done within federal agencies, the federal government also distributes significant funding for public health and disease prevention work to state and local governments, nonprofits and small businesses—funding which has been significantly disrupted. At the CDC, for example, there was a 71.9% decrease in the amount of project grant funding issued in fiscal year 2025 compared to fiscal year 2024. The FDA also issued far less funding in fiscal year 2025—a 21.3% decrease from its fiscal year 2024 funding. Changes in federal funding include the ending of grants to community organizations that worked on HIV prevention and the cancellation of funding for research into improvements to patient safety and healthcare quality. These changes go beyond federal agencies to impact the broader public health ecosystem, including the state and local health departments responsible for much of the on-the-ground public health work in their communities. About 80% of the CDC’s domestic funding is directed towards state and local partners—meaning that cuts to CDC funding can ultimately result in cuts to state and local public health capacity. Federal agencies also provide expertise and assistance to state and local health agencies as they deal with particular health challenges, but workforce cuts have resulted in fewer federal employees available to help. The Impact of Changes to Public Health Capacity These changes to federal public health capacity are not abstract concerns. Disrupted programs, reduced funding and lost expertise at public health agencies across all levels of government threaten the public’s physical well-being and safety. In some cases, this has already led to harm. The most immediate impacts of federal cuts were seen in interruptions to ongoing public health programs and crisis responses. In one instance, when CDC grants were canceled during the 2025 Texas measles outbreak—the most severe measles outbreak in 25 years—public health officials in Lubbock, Texas were forced to pause parts of their measles response work supported by the frozen funding. Lubbock’s director of public health further said that a lack of available CDC experts to reach out to for advice “definitely” impacted the department’s response to the measles crisis. Cuts to federal funding also forced Dallas County Health and Human Services to cut staff and cancel 50 community vaccination clinics during the outbreak. Public health work outside of major outbreak responses was also disrupted. For example, in April 2025, the Milwaukee Public Health Department was unexpectedly unable to reach experts on lead poisoning due to firings at the CDC when responding to concerns about lead contamination in Milwaukee public schools. Due to federal workforce cuts, several programs at the CDC, including Alzheimer’s and epilepsy programs, have also become trapped in limbo—existing on paper, but without the staff necessary to operate. More recent crises reveal how federal cuts have weakened the public health infrastructure needed to prevent and respond to dangerous new outbreaks. Internationally, cuts at the U.S. Agency for International Development eliminated funding for disease testing and contact tracing abroad, which delayed detection of and responses to the 2026 Ebola outbreak in the Democratic Republic of Congo. While international outbreaks may seem far removed, the unchecked spread of disease in any country can quickly pose a danger to economic well-being, security and health around the world. Within the United States, public health cuts inhibited responses to the summer 2026 outbreak of the food-borne parasite cyclospora. At the federal level, cuts to funding for lab equipment and for CDC staff with expertise in parasitic infections—including 9 out of 11 staff members at the lab responsible for identifying parasitic outbreaks in 2025— contributed to the largest reporting delay in outbreak cases at the CDC in 15 years. Conflicting communications from the FDA about the source of the outbreak, which followed cuts to the agency’s communications department, additionally led to confusion among the public about how to best avoid infection. At the same time, cuts to HHS funding and support for local and state public health slowed some health departments’ responses to the crisis. The exact costs of these delays, constraints and confusion in public health responses are difficult to estimate. However, their message is clear: federal cuts have already made containing threats to public health even more of a challenge. Conclusion Protecting public health—from food safety to disease prevention—is one of the federal government’s most important missions. Dramatic and haphazard cuts to federal agencies and funding have already disrupted the public health system, impacting the response to challenges such as measles, lead poisoning and cyclosporiasis. The U.S. public health system needed improvement before these disruptions. Since 2022, federal leadership and coordination in response to public health outbreaks has been on the Government Accountability Office’s High-Risk List of areas in need of attention to improve government effectiveness and efficiency. Recent cuts only compound these concerns. The chaotic dismantling of government and resulting disruptions to crucial functions like public health and disease prevention highlight the need for meaningful reform and concrete policy proposals to reimagine how government can better serve the public and be more effective, responsive and accountable. To learn more about the impact of federal cuts to public health and science more broadly, visit The Cost of Cutting American Science. Learn more For more information on the Partnership for Public Service’s government reform initiative, visit Government for a New Era. View here In line with The Cost of Cutting American Science, federal workforce data in this brief is as of February 2026
Can the Orioles help these players reach their maximum potential?
Baltimore’s roster has been filled with disappointments this season, but a group of young players still possess significant potential.
BBH Launches a New Technology Business, Braid, Solving for Intelligent Data Transformation
BOSTON, September 09, 2026--Brown Brothers Harriman (BBH) today announced the launch of a new technology affiliate, Braid LLC, focused on solving enterprise data transformation for financial services. Braid offers an AI-native data transformation platform that gives firms a scale solution to transform, connect, and manage their data with confidence.
Arsenal to wear uncommon kit combination in Napoli clash
Arsenal are set to wear an all-red kit on Wednesday night against Napoli, ditching the usual white shorts with the red shirt for the first time since 2022.Photo by Justin Setterfield/Getty ImagesArsen...
Harfield's 'surreal' return after 717-day injury lay-off
Aldershot Town defender Ollie Harfield talks about his return to action after a serious knee injury.
Survey: Will the Lions beat the Saints in Week 1?
Checking in with Detroit Lions fans in our latest SB Nation Reacts surveys.
Leeds United handed positive omen vs Chelsea with announcement
Daniel Farke celebrating at Leeds United towards a Chelsea badge
Parkinson demands more from Wrexham after draw
Manager Phil Parkinson acknowledges Wrexham have room for improvement after they were held to a 1-1 draw at home by Burnley.
New York Yankees clinch 34th straight winning season but have much bigger goals
For the New York Yankees, clinching their 34th consecutive winning season was a milepost rather than a milestone. “We're the Yankees, and we're going to win,” captain Aaron Judge said after New York beat the Colorado Rockies 5-3 on Tuesday night for its 82nd victory. New York’s streak is the second-longest in the four major U.S. professional sports leagues behind the Yankees’ record 39 winning seasons in a row from 1926-64.
Photos: Fairfield Ludlowe vs. New Canaan high school field hockey
Photos from Tuesday's season-opening Fairfield Ludlowe vs. New Canaan high school field hockey game.
Guardians Bounce Back With Gritty Win Over Orioles
The Cleveland Guardians stay on pace in the playoff hunt with an impressive win over the Baltimore Orioles.
Pittsburgh Pirates Slim Playoff Hopes No Longer in Their Hands
The Pittsburgh Pirates' playoff hopes are technically still alive, but they'll need a lot of outside help to make it to the postseason.
Tiafoe escapes Michelsen to reach US Open semi-finals
Frances Tiafoe rallied from two sets down -- and 3-0 down in the fifth set -- to edge 22-year-old Alex Michelsen 5-7, 3-6, 7-5, 6-3, 7-6 (10/6) and reach the US Open semi-finals on Tuesday.But in a match of swinging momentum shifts, Tiafoe battled back from 5-3 down in the third set and recovered an early break in the fifth to reach his third US Open semi-final in five years.
Mass. sues Trump admin over efforts to bar trans health care
The lawsuit comes amid growing unease around gender-affirming care for minors in the state
Red Dead Redemption 2 free expansion is a new story set within an alternate timeline
If you need more post-game content, you've found it.
U.S. Department of Health announces key leadership changes at FDA
The U.S. Department of Health and Human Services on Tuesday named four senior leaders at the U.S. Food and Drug Administration, including the heads of its drug center and vaccines and biologics unit.
U.S. Department of Health Announces Key Leadership Changes at FDA
Sept 8 (Reuters) - The U.S. Department of Health and Human Services on Tuesday named four senior leaders at the U.S. Food and Drug Administration, including the heads of its drug center and vaccines and biologics unit. (Reporting by Christy Santhosh in Bengaluru; Editing by Tasim ...
BREAKING: Key Rams Player Is OUT Against The 49ers
Well, so much for seeing Aaron Donald and Myles Garrett together in Week 1. Donald will not travel to Australia with the Rams and has been ruled out for Thursday night’s season opener against the San Francisco 49ers. That’s a major break for Brock Purdy and the 49ers. Donald recently came out of a two-year…
Arsenal youngster in international tug-of-war
Ceadach O’Neill’s international future remains unresolved, with Northern Ireland and the Republic of Ireland both still possible options for the Arsenal youngster.Photo by Cameron Smith/Getty Imag...
HHS Announces Key Leadership Selections at FDA to Promote Innovation, Reform, and National Health Priorities
The U.S. Department of Health and Human Services today announced the selection of four senior leaders at the U.S. Food and Drug Administration.
Arsenal 2-1 Chelsea win changes the transfer-window conversation
Arsenal’s win over Chelsea put the transfer debate into perspective, with the champions showing why their existing squad may already be strong enough.Photo by Ryan Pierse/Getty ImagesI don’t know ...
Artist creates pop art paintings for charity
Quiet conversation intermixed with smooth jazz piano at Asbury United Methodist Church on Friday evening, the old sanctuary providing shelter from the pounding rain for the art enthusiasts gathered within.
Duke HC Manny Diaz Sends Exciting Message Following Opening Win
Duke Blue Devils head coach Manny Diaz sent out an exciting message about the state of the program following the Week 1 win.
Solomon Islands domestic political squabbles could frustrate diplomatic engagement
No confidence motion withdrawn, but experts say volatility could undermine PM Wale’s pivot to Canberra, Washington
'Turning blind eye' to AfD win further angers voters, analyst warns
Chancellor Merz's government must recognise the far-right AfD's victory in Saxony-Anhalt and voter discontent that led to the win, or further cement its downfall, an expert on East German politics warned.
Monday Morning Minnesota: The “Slowly Drifting Away” Edition
So close, and yet so far.
AstraZeneca’s breast cancer pill gets approval from the FDA
AstraZeneca Plc’s breast cancer pill was approved by the U.S.
North Dakota Today - North Dakota Small Business Development Center
recurring recording of North Dakota Today on KVLY
Mexico's star Julián Quiñones earns 2026 Ballon d'Or nomination
Julián Quiñones, the forward for Mexico and Al-Qadsiah, makes the 2026 Ballon d’Or shortlist.
The Business of Building a Medical Practice
We don’t always think about doctors as entrepreneurs, but running a private practice means running a business.
40-goal Crystal Palace youth striker completes Arsenal transfer
Mylo Bernard has completed his transfer to Arsenal, with the Gunners confirming he’s joining on a scholarship deal with professional terms pre-agreed.Photo via Arsenal.comArsenal have officially ann...
AZ's R&D chief Barr touts internal 'science success story' after IL-33 antibody's stellar showing in COPD
With a detailed data drop that AstraZeneca’s R&D chief described as an internal “science success story,” the British Big Pharma has secured an FDA priority review for what it believes could become a flagship biologic in chronic obstructive pulmonary disease (COPD). In detailed results from the late-stage Oberon and Titania trials—first teased in March and detailed in full at the European Respiratory Society Congress in Barcelona this week—the drugmaker laid out the extent of its IL-33 inhibitor’s potential to reduce moderate and severe exacerbations in a wide range of COPD patients still struggling with those “lung attacks,” as AstraZeneca’s Sharon Barr, Ph.D., called them, despite using standard-care inhaled therapy. In the headline results, a 300 mg dose of tozorakimab given once every four weeks curbed those moderate and severe exacerbations in the studies’ primary population of former smokers by 29% in the Oberon study and 34% in Titania. In the overall population of both current and former smokers, these reductions were 30% and 29%, respectively, versus placebo and inhaled standard of care. The benefits also extended to clinically meaningful exacerbation reductions in all prespecified patient subgroups and specifically turned up promising signals in patients across a range of blood eosinophil counts, with Barr telling Fierce that “it’s the details that make this even more exciting than the high-level results that we’ve already shared.” In fact, during AZ’s tozorakimab poster presentation at the ERS 2026 Congress this past weekend, attendees were so enamored by the data that event organizers had to encourage people to clear the room and look at the other presentations on offer, Barr said in an interview. “I think it really speaks to the fact that there is a lot of buzz around these data because the entire respiratory community has been so desperate for new therapies for these patients,” she explained. The respiratory disease continues to represent a “staggering unmet medical need,” Barr said, highlighting the COPD exacerbations that the Oberon and Titania studies homed in on, which she added carry a greater mortality risk than a heart attack. “When a patient has a severe exacerbation, only about half of them are still alive within three and a half years,” she pointed out. As for tozorakimab specifically, Barr christened the molecule “an AstraZeneca science success story,” harkening several years back to the point at which researchers began to explore IL-33 as a driver of respiratory disease, and COPD in particular. At the same time, “there was still so much that wasn’t understood,” she admitted, highlighting the insight that IL-33 signals through both ST2 and EGFR through the RAGE pathway, a discovery Barr attributed to AstraZeneca's own scientists. Understanding the need to tackle both pathways in COPD—and aware of competitor candidates in the hopper, including one that bound ST2—the company ultimately had to make some “courageous decisions,” Barr said. These included taking a prior COPD molecule offline and going back to the drawing board to reinvent its potential IL-33 label “to make sure that we had a molecule that could block signaling through both arms of the pathway, through both the reduced form and the oxidized form, knowing that we wouldn’t be first, but striving to be best.” “When we put [tozorakimab] into the clinic, we firmly believed that we had a differentiated molecule, and we saw the other molecules blocking just ST2 or partially blocking IL-33, unable to deliver two positive pivotal studies in COPD,” Barr explained. “We kept marching forward because we believed our molecule was differentiated, and now I think we have the clinical validation that supports that.” Ultimately, AstraZeneca finds itself on much better footing these days when it comes to potential biologic rivals to tozorakimab in COPD. Sanofi and Regeneron’s Dupixent, for instance, is approved to treat COPD exacerbations in patients with high eosinophil counts, but not low ones. Meanwhile, the future has become cloudier for other next-gen IL-33 candidates from Sanofi and Regeneron, as well as Roche, which have suffered trial flops in recent years. One other potential ingredient for AstraZeneca’s success in its duo of studies was that the company was “ambitious in the trial design, willing to look at an all-comers population,” Barr said, “and willing to enroll the most severe patients.” Prior studies for would-be biologics rivals in COPD “avoided enrolling” those patients, she pointed out. She also highlighted the Big Pharma’s painstaking design of exacerbations in its trial, which “gave us a very rigorous readout,” and pointed to “the extra effort and investment” the company put in to understand the effect of mucus plugs in patients. Barr described mucus production as a “key feature in disease diversity,” noting that mucus plugs—obstructing clumps of mucus that block patients’ airways—are associated with worse outcomes in COPD. In its data announcement, AstraZeneca noted that an integrated analysis of Oberon and Titania found tozorakimab “demonstrated a reduction in patients’ mucus plug score,” with the pharma claiming its biologic is the first to deliver such results in a broad COPD population. “So being able to reduce those mucus plugs, we expect, is an important part of driving benefit for patients who are living with COPD,” Barr said. Again touching on the breadth of the study populations, Barr added that tozorakimab “worked across all eosinophil levels in both current and former smokers across all levels of lung function,” which she suggested “really simplifies decision-making for clinicians, and it allows them to offer therapy to the broadest possible patient population.” In the highest patient eosinophil count group, tozorakimab helped chart a 43% reduction in exacerbation risk, which Barr stressed were “unprecedented data.” In the mid-level group, AZ’s drug delivered a 23% reduction and, in the lowest group, a 34% reduction in eosinophils, which Barr said suggests efficacy “in all patient subgroups.” As for AZ’s recent guidance upgrade on the medicine’s sales opportunity, the lift from a $3 billion to $5 billion range to $5 billion plus was informed by multiple factors, Barr said, including the fact that “in 2024, there were multiple competitors, and there aren’t anymore.” Additionally, “we know that this is a massive unmet medical need, and this is a really incredible set of data that we think will be very convincing to the clinical community,” Barr said. Looking ahead to a potential evolution of the COPD treatment landscape, Barr noted that most patients start treatment in the community with an option like a triple therapy, and for them, having an option like AstraZeneca’s inhaler Breztri will remain a “really important part” of that journey. But of the patients uncontrolled on triple therapy, which Barr described as “about half of them today,” just a “small fraction” are currently eligible for biologic therapy, which she emphasized AstraZeneca is working to change. Understanding that COPD is not a “one-size-fits-all” disease, AstraZeneca is also looking at its antibody drug Tezspire for patients with T2-driven disease, and the company continues to think about new mechanisms for tackling COPD through both systemic and inhaled drugs, Barr said.
Projecting the Eagles’ starting defense against Washington in Week 1
Projecting Vic Fangio’s defensive starters for Philadelphia’s Week 1 matchup.
Kamin Science Center using multi-day closure to refresh exhibits on all floors
Officials say the museum is using the mid-week closure to refresh and maintain exhibits and visitor experience across all five floors.
'Preposterous.' 6 Washingtonians on how the high cost of living affects their lives
KUOW spoke with six Washingtonians of varying income levels about how the region's high cost of living is affecting them — and potentially how they'll vote this fall.
Oura goes public, reported $1.2B earnings in its last fiscal year
In health tech news today, Oura reports a profit, the FDA loses another key digital health leader, and more
Cyclospora outbreak followed years of declining FDA foreign inspections
FDA inspections of foreign food sites are down nearly 35% since 2019, according to agency records reviewed by The Associated Press
Scott McTominay has successful heart surgery as return timeframe revealed
Napoli released a statement on Tuesday following McTominay’s heart procedure
Why a cannabis business is betting on dogs to reach FDA approval
Endovia is pursuing FDA veterinary approval for its cannabinoid drug targeting canine cancer and chronic pain in the companion-animal market.
More than 1.6 million people die each year from secondhand smoke
The share of the population exposed to tobacco smoke is falling, but more than 2.7 billion people worldwide are still affected
Arsenal summer signing in contention for Napoli start
Bruno Guimaraes should be in contention to start for Arsenal against Napoli on Wednesday in the team’s Champions League opener, according to a report.Photo by Shaun Botterill/Getty ImagesArsenal hav...
🏈 Y! Sports AM: Week 1 gets weird
College football kicked off with a clock controversy and a power outage.
Chelsea captain makes excuses after Arsenal defeat
Reece James suggested the Arsenal squad’s long time spent together helped them to overcome Chelsea on Sunday, but have the Gunners really had that much stability in the team?Photo by Justin Setterfi...
Alabama Department of Mental Health highlights life-saving resources for Prevention, Recovery Months
This September, the Alabama Department of Mental Health and statewide partners are working to raise awareness, fight stigma, and share life-saving resources.
Alabama Department of Mental Health highlights life-saving resources for Prevention, Recovery Months
This September, the Alabama Department of Mental Health and statewide partners are working to raise awareness, fight stigma, and share life-saving resources.
Alabama Department of Mental Health highlights life-saving resources for Prevention, Recovery Months
This September, the Alabama Department of Mental Health and statewide partners are working to raise awareness, fight stigma, and share life-saving resources.
Arsenal reveal early double injury update before Napoli clash
Jurrien Timber joined Arsenal training on Tuesday morning, but there was no sign of Cristhian Mosquera ahead of Wednesday’s clash with Napoli in the Champions League. The Gunners squad were on show at the club’s Sobha Realty training base for an open session before flying out to Naples later in the day. Timber, who has not played a minute so far this season, continues to step up his recovery from the minor groin surgery he had over the summer.
Former ref explains Arsenal-Chelsea red-card decision
Dermot Gallagher has backed the referee’s decision not to send off Gabriel Magalhaes for a kick to Emi Martinez’s head, explaining that the defender got the ball.Photo by Ryan Pierse/Getty ImagesA...
How the political climate Andy Harris helped create has come for him
The far-right Republican leader has twice dodged redistricting attempts. He may not be so lucky a third time.
Reynolds is selling fruity new vapes unauthorized by FDA
The decision to move ahead with new products in the absence of FDA authorization could spur other big manufacturers to do the same, one tobacco-nicotine expert said.
Predicted Borussia Dortmund XI vs. Villarreal: BVB duo absent
Borussia Dortmund begin their UEFA Champions League campaign at home to La Liga side Villarreal at the Westfalenstadion on Tuesday evening, but they will have to do without an additional two first tea...
Aaron Donald makes no guarantees ahead of 49ers game
Aaron Donald feels great. Better, in fact, than he expected after two full seasons away from football. One week into one of the most fascinating comebacks in NFL history, Donald...
New York Giants release Darius Slayton, their longest-tenured player
Darius Slayton had been the longest tenured player on the Giants roster before the team announced his release on Monday.
For Sandra Bullock and Nicole Kidman, ‘Practical Magic 2’ heals old wounds
Sandra Bullock and Nicole Kidman view “Practical Magic” very differently today than they did when they made it 28 years ago.
Syracuse football: Fran Brown expects players to be back soon
A few impact players could be ready to go for Syracuse’s first ACC game
I feel 100% fit now, says Nunes
Matheus Nunes says he’s fully fit now ahead of City’s Champions League opener against FC Porto. Men's Team Subscribe to CITY+ for live audio commentary of FC Porto clash The Portuguese internation...
National high school football rankings: Upsets reshape USA TODAY Sports Super 50
Check the current 2026 season records for top high school football programs across every state in the country.
Royals vs. Diamondbacks, September 7 Live Discussion
Noah Cameron gets the start on a holiday matinee against a team hanging on to a Wild Card spot.
KC Current announces departure of Vlatko Andonovski
In a major surprise, Vlatko Andonovski is out at Kansas City Current after making history at the club during the 2025 NWSL season.
Sydney Sweeney and Robert Pattinson lead the standout looks on Venice Film Festival red carpet
From John Malkovich's ruff to Nina Dobrev's vintage Armani gown, there's a lot to unpack.
Serie A: Cagliari vs. Lecce
Fabio Pisacane and Eusebio Di Francesco have confirmed their selections as Cagliari host Lecce at the Unipol Domus in the penultimate match in the third round of 2026-27 Serie A fixtures.Cagliari have...
Former Gunner receives 4-match Champions League ban
Matteo Guendouzi has received a four-match Champions League ban after insults and provocations during Fenerbahce’s recent game against Lyon, though two matches are suspended.Photo by Ahmad Mora/Gett...
Anthony Edwards: "A lot of players don't talk trash, …
Anthony Edwards: "A lot of players don't talk trash, …
Ed Sheeran concert: Politics vs music outrage
An Ed Sheeran fan says he left the concert disappointed after opening act Macklemore delivered political remarks.
The Optimist: Taxing depth early as a sign of progress
It won't be a smooth road, but the Panthers might actually have a car capable of driving on dirt for the first time in years
Seedy K’s GameCap: Ole Miss
Last night’s was the first Cardinal football game since The Professor passed away. He loved college football. He loved the U of L Cards. His spirit force was strong with me during last night’s opener, a self inflicted 38-41 L to Ole Miss in the Music City Something or Another in NashVegas. Specifically felt his […]
Pro Football Focus details Texas A&M QB's successful 2026 debut
PFF provided Texas A&M QB Marcel Reed's day through the air on Saturday, detailing his deep throw grade and improved decision making when pressured.
Do De Zerbi's 'football manager' comments 'ring hollow'?
The Telegraph's Luke Edwards says Roberto de Zerbi's comments that "you can't just build the team with the names like in Football Manager" after his Tottenham side drew against Nottingham Forest on Saturday "ring a little bit hollow". After a goalless draw at the City Ground left Spurs still searching for a first win of the season, head coach De Zerbi also told Sky Sports Spurs "have to improve in every part of football, organisation with and without the ball".
Millwall 4-0 Bolton
Millwall and Bolton fans give their reaction to the Lions' 4-0 Championship win over the Trotters.